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Abstract. Monoclonal antibodies (MAbs) 32F1 and 32F3 react with two independent epitopes of a protein doublet 
with molecular weights of 48 and 45 kilodaltons (kD) expressed on the surface o f Plasmodium falciparum (Pfs48/ 
45) macrogametes and zygotes; only 32F3 blocks transmission. These MAbs were used to develop a Pfs48/45~specific 
competition enzyme-linked immunosorbent assay (ELISA) using 32F1 to capture antigen and labeled 32F3 for quan­
tification and analysis of the contribution of antibodies in human serum to transmission-blocking activity. A com­
parison analysis was used to determine agreement of competition ELISA titers and transmission-blocking activity as 
observed in the bioassay in three groups of serum samples: 37 from European travelers with previous exposure to 
malaria, 56 from gametocyte carriers, and 66 from schoolchildren from a malaria-endemic area in Cameroon. The 
index of agreement between outcomes of the ELISA and transmission-blocking assay in gametocyte carriers and in 
travelers was specifically defined as fair-to-moderate; in schoolchildren the agreement was not significant. The com­
bined analysis of all sera showed a significant and fai r-to-moderate agreement between the results of the competition 
ELISA and the transmission-blocking assay, with a relative specificity of 94% (of 105 cases negative in the trans­
mission-blocking assay, 99 were also negative in the competition ELISA) and a relative sensitivity of 44% (of 54 
cases positive in the transmission-blocking assay, 24 were also positive in the competition ELISA). This study shows 
that a positive C48/45-ELISA is indicative for transmission-blocking activity in the mosquito assay, while a negative 
result does not exclude transmission-blocking activity.
Gametocytes of Plasmodium falciparum  synthesize 230- 
and 48/45-kilodalton (kD) molecules that remain exposed on
the surface of macrogametes and zygotes.1“'3 Several mono­
clonal antibodies (MAbs) directed against these molecules 
block transmission of the parasite to the mosquito vector. 
One of the targets of transmission-blocking MAbs is the 48/ 
45-kD glycoprotein doublet (Pfs48/45). Two independent, 
nonrepetitive epitopes of this protein react respectively with 
MAbs designated 32F1 and 32F3. The presence of 32F3 in 
a mosquito blood meal blocks transmission of the NF54 iso­
late of P. falciparum while 32F1 does not.4 The conventional 
assay measuring transmission reduction in mosquitoes using 
a feeder system, as described by Vermeulen and others,1 is 
costly, labor intensive, and thus limits the number of sera 
that can be tested. Development of a serologic test predicting 
transmission-blocking activity would greatly simplify epi­
demiologic studies. A positive correlation between antibody 
reactivity to Pfs230 and transmission-blocking activity has 
been found using immunoprécipitation to quantify the anti­
body response. Such a relation was not found for antibody 
reactivity to
This paper describes the development of a two-site com­
petition enzyme-linked immunosorbent assay (ELISA) based 
on the 32F3 epitope. This competition ELISA was used to 
analyze several sets of field sera. In addition, the transmis­
sion-blocking activity of these field sera was determined us­
ing the feeder assay1 and the results obtained were compared 
with those of the competition ELISA using a statistical anal­
ysis for comparison of methods.6'7
MATERIALS AND METHODS
Parasites and Pfs48/45 extract. Mature gametocytes of 
P. falciparum (isolate NF54) were produced in an automat­
ed, large-scale, culture system as described by Ponnudurai 
and others.8 Gametogenesis was induced by incubating the 
mature gametocytes in fetal calf serum (FCS) at room tem­
perature for 30 min. Macrogametes and zygotes were puri­
fied as described by Vermeulen and others.1 Pelleted para­
sites were stored at —70°C until use. For use in sandwich 
competition ELISA experiments, Pfs48/45 was extracted in 
25 mM Tris-HCl, pH 8.0, containing 0.5% Nonidet P40 
(NP40), 1 mM phenylmethylsulfonyl fluoride, and 1 (xg/ml 
each of DNase and RNase. Insoluble debris was pelleted by 
centrifugation (16,000 X g for 5 min at room temperature) 
and the soluble protein extract was stored at —70°C. The 
presence and quantity of Pfs48/45 in the extract was deter­
mined in a sandwich ELISA using labeled 32F3 and 32F1.
Transmission-blocking assay. A with mem­
brane feeders to feed mosquitoes was used to determine 
transmission-blocking activity.'■ 10 Briefly, while keeping 
the temperature at 37°C, 14-day-old cultures containing fer­
tile gametocytes were mixed with prewarmed uninfected red 
blood cells and samples of human sera or MAbs, introduced 
in prewarmed feeders, and fed to Anopheles gambiae mos­
quitoes. All samples were tested in two experiments in the 
presence of complement. The minimal obtainable dilution of 
the sera was three-fold and the IgG preparations of blocking 
sera were retested using a 10-fold dilution with the malaria- 
negative control serum. Fully engorged mosquitoes were 
separated and held at 26°C. Seven days later, 20 mosquitoes 
per feeder were dissected and the number of oocysts on the 
stomach wall was counted and William’s mean (adjusted 
geometric mean) oocysts number was calculated." An ex­
periment was deemed to have succeeded when at least 90% 
of the mosquitoes examined earned oocysts in each of three 
controls. The adjusted geometric mean was used to deter­
mine the reduction activity (R) according to the equation: R
6 0
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( ' I ' , V • r* V« r¡)/T\. X 100%, where T¡ is the geometric m ean for
the test feeder and Tv. is the mean of the three controls. If 
the transmission-réduction value of a given serum was less 
than 85%, a considerable variation could be observed among
tests. Values greater than 85% werei
consistent in subsequent experiments and only those were
this paper.
as positive in the transmission-blocking assay in
of transmission in the feeder assay was 
immunoglobulin fraction of these sera, 
um samples were obtained from the fol­
lowing groups: I ) 56 gametocyte carriers (6-36 years o f age)
2 , Cameroon,12 2) 37 Eu­re cru i ted at a sary in
ropean travelers (6-70  years of age) to malarious regions 
with antibody titers to P. fieldi asexual parasites determined
•escenee assay, and 3) 66 school-
children (8 12 years o f age) from Edea, Cameroon.1* A pan­
el o f  individual and pooled sera from Dutch blood bank do­
nors without previous malaria experience was used as 
negative controls. As a positive control in every test, the 
serum from one individual who had worked in a malaria area 
in Tanzania for more than 30 years was included. Comple­
ment was acquired from freshly obtained AB blood from
blood bank donors, without previous malaria experi­
ence, by allowing the blood to clot at room temperature for 
1 hr. Aliquots o f the resulting serum were stored at —70°C
Sandwich competition ELISA (C48/45-ELISA). Biotin 
labeling o f MAb 32F3 was performed according to the pro­
cedure described by Verhave and others,14 and horseradish 
peroxidase (HRPO) labeling following the periodate method 
using an input HRPO:lgG molar ratio of four was carried
method described by Wilson and Nak- 
ane.15 The labeled MAbs were dialyzed against phosphate-
saline (PBS). suoDlemented with thimerosal
(0.01%) and PCS (1%) and stored at 4°C.
The basic procedure was that of the two-site ELISA. All 
incubations were carried out at room temperature. To capture 
Pfs48/45, wells of microtiter plates (Hycult, Uden, 
Netherlands) were coated with 50 |xl of a 10 (xg/ml concen­
tration of 32F1 in PBS for 45 min. Plates were washed three 
times with PBS. Wells were saturated with 150 jxl of 2% 
bovine serum albumin in PBS lor 30 min. After three washes 
with PBS, the wells were incubated for 2 hr with 50 |xl of 
the NP40 parasite extract (see above) containing the equiv­
alent of 200,000 gametes/zygotes diluted in TNP (25 mM 
Tris-HO, pH 8.0, 150 niM NaCl, 0.1% NP40). Following 
three washes with PBS, wells were incubated with 30 |xl of 
test serum sample and 30 |xl of labeled 32F3 for 2 hr. For 
biotin label, an additional incubation step with streptav-
(1:3,000
T a b l e  1
Guideline for  the interpretation of the index of agreement kappa (K )
Value of K Strength o f  ag reem ent
< 0.20
0.21-0.40
0.41-0.60
0.61-0.80
0.81- 1.00
Poor
Fair
Moderate
Good
Very good
1/20 w ere
were tested in a checkerboard titration. From this antigen- 
antibody titration, concentrations of labeled M Ab and anti­
gen were chosen resulting in >  60% of the maximal OD o f  
labeled MAb and an OD reading >  1.0.
Competition was defined as a reduction in the OD reading 
obtained with the MAb alone in the presence o f  a negative  
control serum. The true endpoint was defined as the dilution  
(titer) at which the positive sample reaches the OD value o f  
the negative control. Sera with true endpoint 
considered positive.
Comparison of the transmission-blocking assay a n d  
competition ELISA. The results of the competition ELISA  
were compared with those obtained by the transmission- 
blocking assay and analyzed by a statistical test on agree­
ment using a calculated index of observed agreement.6-7 T h e  
index kappa (K) was calculated from the observed and e x ­
pected (by chance) frequencies on the diagonal of the 2 X 
2 table of transmission-blocking activity outcom es in th e
( 85%, < 85%) and results of the com petition
ELISA (positive, negative). The index is given by K ( P o
Pc) / 1 P„, where
n
1) P0 is the observed proportional agreement, i.e., P0
¡ = i
fi¡ /n, where f¡¡ is the number of agreement for category i (i 
= 1,2) and n is the number of examined sera, and
2) Pc is the expected proportional agreement by chance, i.e ., 
= T  r¡c¡/n2, where r¡ and c¡ are the row and column totalsP..
for the i lh category (i 1 , 2 ).
The approximate error of K is SE(K) P o d P0)
n ( l P,)2
and th e
approximate 95% confidence interval is given by K ± 1.96
The index of agreement K has a maximum of 1.00 w hen  
agreement is perfect; values of zero or less indicate no agree­
ment While i n
terpretation is possible, the guideline proposed by Altm an6 
rween-20; Amersham Life Sciences, was used to determine the strength of agreement (Table 1).
biotinylated 
containing 0.
togenboseh, The Netherlands) preceded the incubation
, For both labels, the wells were
I
I
with
washed four times with PBS and incubated lor 20 min with 
60 |xl of TMB (0.25 niM 3,3',5,5'-tetramethyl benzidine, 0.7
mM HUO, in 0.1 M sodium acetate, pH 5.5) substrate solu-
th -  * *  *
lion. The peroxidase substrate reaction was stopped by add­
ing 60 |xl of 2 M 1 1 1  SO., and the optical density (OD) was 
determined in an ELISA reader at 450 nm (Titertek Multis- 
kan MCC7340; ICN, Zoetermeer
For optimal immunoreaetions, labeled MAbs and antigen
R ESU LTS
serum
MAb
optimal amount of antigen coated per well as determined in 
the checkerboard titrations were 2 (xg/ml for the biotin label 
and 200,000 macrogamete/zygote equivalents/well, and I 
|xg/ml for the HRPO label and 100,000 m acrogam ete/zygote 
equivalents/well, respectively. The maximal OD o f the
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Figure 1. Two-site competition enzyme-linked immunosorbent assay. Monoclonal antibody (MAb) 32F1 was used to capture Pfs48/45 
from an NP-40 extract. -I- = horseradish peroxidase (HRPO)-32F3 (1 ¡xg/ml with 100,000 macrogamete/zygote equivalents/well) and A = 
biotin-32F3 (2 |xg/ml with 200,000 macrogamete/zygote equivalents/well) were used as labels in competition with serial dilutions of unlabeled 
32F3. The horizontal dotted line represents the 50% competition value and the vertical dotted lines represent the concentration of unlabeled 
MAb needed to arrive at a 50% competition with the labeled MAb.
HRPO-32F3 label was higher than that of the biotin-32F3 
label using the same concentration of antigen. Competition 
of labeled MAb with increasing concentrations of unlabeled 
MAb is depicted in Figure 1. The 50% competition values 
of the corresponding unlabeled MAb were 0.25 |xg/ml for 
the 1.0 (JLg/ml HRPO label and 1.3 (xg/ml for the 2.0 fxg/ml 
biotin label. In addition, it appeared that the biotin-32F3 
competition ELISA was positive, with seven of 19 sera hav­
ing positive transmission-blocking activity as observed in 
the bioassay, whereas the HRPO-32F3 competition was pos­
itive for nine of 19 sera. Due to the limited sensitivity of the 
biotin-32F3 competition ELISA, human sera could not be 
diluted more than 1:10, preventing a complete titration of 
the sera. The MAb 32F1 (anti-Pfs48/45) and MAbs against 
the 25-kD and 230-kD antigens were negative in the com­
petition test up to a concentration of 330 (xg/ml.
Figure 2 shows examples of the competition of serial di­
lutions o f sera with the HRPO-32F3 label. Data of the neg­
ative serum are the mean of 14 individual sera tested on 
three separate occasions. Calculation o f the overall intra-as­
say variation resulted in an average deviation of the mean 
OD of 0.08 (10%). The overall interassay variation resulted 
in an average deviation of the mean OD of 0 . 11 (14%). The 
titration values of three sera that were positive in the com­
petition ELISA are depicted using the overall mean of du­
plicate determinations o f two independent tests.
Control experiments with 14 sera from Dutch blood bank 
donors exhibited a nonspecific reduction up to a maximum 
of 15% o f the OD of the HRPO-32F3 label compared with 
reactions without competing serum antibodies. This nonspe­
cific reduction was not seen with IgG preparations of these 
sera. Nevertheless, the competition titer found for sera and 
their corresponding IgG preparations were the same.
Comparison of competition ELISA and transmission-
OD at 450 nm
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0.40
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Figure 2. Inhibition of binding of horseradish peroxidase (HRPO)-32F3 in the presence of serial dilutions of human serum. Negative 
serum (O); each data point represents the mean ± SD of 14 determinations performed on three different days. (A, A, and -I-) = three sera 
positive in the competition enzyme-linked immunosorbent assay. Each data point represents the mean of duplicate determinations performed 
on two days. OD = optical density. For concentrations of antigen and HRPO-32F3, see Figure 1 .
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T a b l e  2
Activity in the Pfs48/45 competition enzyme-linked immunosorbent 
assay (C48/45-ELISA) and in the transmission-blocking (TB) as­
say in sera of gametocyte carriers, travelers, and schoolchildren
TB assay
C48/45-ELISA results
56 gametocyte carriers 37 travellers 66 school children
No.
positive
No.
negative
No.
positive
No.
negative
No.
positive
No.
negative
> 8 5 % 1 3 1 2 9 1 0 2 8
< 8 5 % 4 2 7 0 1 8 2 5 4
Total 1 7 3 9 9 2 8 4 6 2
blocking assay in several groups of sera. Table 2 shows 
the results of the competition ELISA and the transmission- 
blocking assay for the sera of gametocyte carriers, travelers, 
and schoolchildren. Using the HRPO-32F3 label, 17 (30%) 
of 56 of the gametocyte carriers exhibited significant com­
petition in the ELISA. These results were compared with the 
corresponding transmission-blocking activity observed in the 
bioassay. By shifting the transmission-blocking assay cutoff 
point in the gametocyte carrier group in the range of 10% 
to 90%, it appeared that the maximum degree of agreement 
between the transmission-blocking assay and the C48/45- 
ELISA was at the 85% reduction point. Furthermore, it ap­
peared that the agreement between the transmission-blocking 
assay and the C48/45-ELISA was not greater than chance if  
the cutoff point of the transmission-blocking assay was set 
at a reduction lower than 70% (95% confidence interval of 
K included the value 0). At the 85% reduction point, the 
index K assumed the value 0.40, indicating fair-to-moderate 
agreement between the outcomes of the competition ELISA 
and the transmission-blocking assay (Table 3). Four of the 
17 positive sera from gametocyte carriers in the C48/45- 
ELISA test had oocyst counts that did not meet the 85% 
reduction standard. Of the 25 sera that were positive in the 
transmission-blocking assay, 13 had antibodies competing 
with the HRPO-32F3 MAb, indicating a relative sensitivity 
of 52%. Of 31 sera considered negative by the transmission- 
blocking assay, 27 were also found to be negative by the 
C48/45-ELISA, showing a relative specificity of 87% for the 
competition ELISA.
Nine (24%) of 37 travelers exhibited significant activity 
in the ELISA. Nine (47%) of 19 sera positive in the trans- 
mission-blocking assay had antibodies competing with the 
HRPO-32F3 MAb. All 18 sera considered negative by the 
transmission-blocking assay were also negative by the C48/ 
45-ELISA. The index o f agreement K between the 
transmission-blocking assay and the C48/45-ELISA for the 
group of travelers assumed a value of 0.47, indicating mod­
erate agreement (Table 3).
T a b l e  4
Comparison of activity in the transmission-blocking (TB) assay and 
iti the Pfs48/45 competition enzyme-linked immunosorbent assay 
(C48/45-ELISA) in all field sera combined*
TB assay
C48/45-ELISA results
No. positive No. negative Total
> 8 5 % 2 4 3 0 5 4
< 8 5 % 6 9 9 1 0 5
Total 3 0 1 2 9 1 5 9
* Relative specificity = 94% (99 or 105); relative sensitivity =  44% (24 or 54); index 
of agreement K = 0,44.
Four (6%) of 66 sera of schoolchildren showed significant 
competition in the ELISA. Only 2 (20%) of 10 sera positive 
in the transmission-blocking assay were positive in the com­
petition ELISA. The relative specificity was 96% (54 of 56). 
The index of agreement K between the results of the C48/ 
45-ELISA and the transmission-blocking assay was low with 
a wide confidence interval (K = 0.22, 95% confidence in­
terval = —0.23, 0.67). Since the confidence interval contains 
zero, chance can explain the observed level of agreement.
A summary of the data of the three groups combined is 
given in Table 4. The index of agreement K between the 
results of the C48/45-ELISA and the transmission-blocking 
assay was K = 0.44; with a 95% confidence interval of 0.28,
0.60, indicating fair-to-moderate agreement (Table 1). The 
ELISA outcomes show a relative specificity of 94% (99 of 
105) and a relative sensitivity of 44% (24 of 54).
DISCUSSION
An MAb-based competition ELISA was developed to 
study the natural antibody reactivity to Pfs48/45 in field sera 
in comparison with transmission-blocking activity as ob­
served in a bioassay. The 32F3-labeled MAb was used in 
this competition ELISA because of its blocking activity in 
the transmission-blocking assay. Competition of antibodies 
in field sera with labeled 32F3 for binding to Pfs48/45 might
therefore be relevant for transmission-blocking activity. 
Transmission blockade has not been found in serum of rab­
bits immunized with recombinant Pfs48/45 (Roeffen W and 
others, unpublished data). Therefore, Pfs48/45 extract from 
parasites was used as antigen in the competition ELISA.
The concentration of unlabeled antibody necessary to re­
duce binding of the labeled MAb in the competition ELISA 
was lower for HRPO-labeled 32F3 than for biotin-labeled 
32F3. This was supported by the observation that in the 
competition ELISA with HRPO-32F3 as label, nine of 19 
blocking field sera were positive in contrast to seven of 19 
when biotin-32F3 was used. Therefore, HRPO-labeled 32F3
T a b l e  3
Comparison o f activity by index of agreement K  in the Pfs48/45 competition enzyme-linked immunosorbent assay (C48/45-ELISA) and the 
transmission-blocking assay in sera of gametocyte carriers, travelers, and schoolchildren
Group n
Index of agreement K
K 95% confidence interval Strength
Gametocyte carriers 5 6 0 . 4 0 0 . 1 5 - 0 . 6 5 Fair to moderate
Travelers 3 7 0 . 4 7 0 . 1 9 - 0 . 7 5 Fair to moderate
Schoolchildren 6 6 0 . 2 2 - 0 . 2 3 - 0 . 6 7 Not significant
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was; used in the competition ELISAs of subsequent experi­
ments.
Transmission-blocking activity was found in a high pro­
portion of sera from gametocyte carriers and travelers to 
malarious regions. In the group of travelers, all sera positive 
in the C48/45-ELISA blocked transmission, but 10 of 19 
blockers were negative in the C48/45-ELISA. The Pfs48/45 
epitope has several, surface-exposed domains recognized by 
MAbs.1617 Since only one domain potentially involved in 
blocking activity could be analyzed in this study, reactivity 
to other domains might explain why 10 o f 19 blockers were 
negative in the C48/45-ELISA. Since sera from people living 
in endemic areas react to all epitopes tested on the Pfs230, 
several alternative explanations may be considered. It may 
be that blocking reactivity is targeted to molecules other than 
that of Pfs48/45, or that blocking does not only depend on
IK
antibody, but may also be caused by nonspecific factors as 
observed in P. vivax and P. falciparum  infections.19 In our 
analyses, it appeared, however, that IgG fractions of sera 
with transmission-blocking activity also blocked transmis­
sion. Although this does not exclude the presence of non­
specific transmission-blocking activity, specific activity can 
explain the results. It is also possible that the C48/45-ELISA 
is less sensitive than the transmission-blocking assay.
The results for the gametocyte carriers and schoolchildren 
were also problematic because four of 17 and two of four 
sera positive in the C48/45-ELISA, respectively, were in the 
nonblocking group (<  85%). It should be noted that the cat­
egory R <  85% in the transmission-blocking assay does not 
necessarily mean that there is no transmission reduction. It 
only shows that repeated experiments with sera from this 
group exhibited considerable variation o f the transmission- 
réduction value, making it impossible to subdivide the group 
with R values <  85% in different subclasses.
A statistical test for comparison of proportions or asso­
ciation is not considered appropriate for the comparison of 
the outcomes of the transmission-blocking assay and the 
C48/45-ELISA. Besides sensitivity and specificity, measure­
ment of agreement rather than association is required. The 
kappa (K) measure, which measures the amount of agree­
ment beyond chance, seems to (it our purpose. In two of 
three groups of sera, agreement was significant, (fair-to-mod­
erate for gametocyte carriers and travelers) and only in the 
group of schoolchildren could agreement between the out­
comes of the two methods be explained by chance. Never­
theless, overall a fair-to-moderate agreement was found. In
, the C48/45-ELISA exh ib ited  reasonable lev e ls  o f  
sen sitiv ity  (S: 44%) and sp ec ific ity  ( s
In a Papua New Guinea study, an MAb (MAb IIC5B10) 
specifically reacting with an epitope o f Pfs48/45 was used 
to compete with a panel of field sera in a Pfs48/45 compe­
tition ELISA. The results of this competition ELISA did not 
correlate with either the capacity of these field sera to pre­
cipitate Pfs48/45 from a radiolabeled gametocyte extract or 
the transmission-blocking activity observed in these same 
field sera.20
On the other hand, the analyses of the Papua New Guinea 
sera revealed a correlation between serologic reactivity to 
Pfs230, but not to Pfs48/45, and transmission-blocking ac­
tivity.5 Our competition ELISA is specific (94%), but only 
positive in 44% o f the sera with transmission-blocking ac­
tivity. This leaves the possibility that the competition ELISA 
is insensitive or that the transmission-blocking activity in 
these sera is directed to other sexual stage molecules, e.g., 
Pfs230 as observed by Graves and others.5
In summary, the transmission-blocking bioassay is a cost­
ly, comparatively labor-intensive, and time-consuming test. 
A Pfs48/45 epitope-specific competition ELISA has a sig­
nificant predictive value to the transmission-blocking activ­
ity, which is limited by the fact that only 44% of all trans­
mission-blocking sera are positive in the competition ELISA. 
This indicates the need to increase the sensitivity o f the test 
and/or to define additional transmission-blocking targets.
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